Susan G. Komen's ShareForCures

Sponsor
Susan G. Komen Breast Cancer Foundation (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05654246
Collaborator
(none)
200,000
1
119.5
1673.8

Study Details

Study Description

Brief Summary

ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    ShareForCures (SFC) will be a people-powered, data-driven breast cancer registry that will provide a way for individuals from diverse backgrounds to participate in research and enable participants' data to be used for breast cancer research. The overarching goal of SFC is to create a robust research resource comprised of clinical, biological, socio-behavioral, and other data from up to 200,000 people with breast cancer-including minoritized and historically marginalized people, persons, or communities-to ensure the data, researchers use to study breast cancer, is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer and everyone can potentially benefit from scientific advances and improvements in care.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200000 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry
    Actual Study Start Date :
    Nov 17, 2022
    Anticipated Primary Completion Date :
    Nov 1, 2032
    Anticipated Study Completion Date :
    Nov 1, 2032

    Outcome Measures

    Primary Outcome Measures

    1. Engage participants representative of the United States breast cancer patient population in ShareForCures. [10 years]

      Enroll and engage up to 200,000 people, who have been diagnosed with breast cancer, reflecting the diversity of breast cancer survivors within the United States, to participate in the registry as our partners in research.

    2. Integrate participant data into ShareForCures. [10 years]

      Collect and curate a rich scope of participant data from a variety of sources (including participant-provided information, clinical records, and linkage to other existing datasets) and biospecimens to create a comprehensive, longitudinal database.

    3. Facilitate scientific research using ShareForCures data. [10 years]

      Make deidentified data available to researchers for scientific discoveries, including research that may lead to new knowledge about breast cancer and advances in patient care and outcomes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).

    • Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.

    • Individuals must be currently residing in the United States or a territory of the United States.

    • Individuals must be able to read and understand English.

    Exclusion Criteria:
    • Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).

    • Individuals without a diagnosis of breast cancer.

    • Individuals who are not residing in the United States or a territory of the United States.

    • Individuals unable to read and understand English.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Susan G. Komen Dallas Texas United States 75380

    Sponsors and Collaborators

    • Susan G. Komen Breast Cancer Foundation

    Investigators

    • Principal Investigator: Jerome Jourquin, Ph.D., M.S., Susan G. Komen

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Susan G. Komen Breast Cancer Foundation
    ClinicalTrials.gov Identifier:
    NCT05654246
    Other Study ID Numbers:
    • SGK-SFC-001
    First Posted:
    Dec 16, 2022
    Last Update Posted:
    Dec 16, 2022
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 16, 2022